OrthoPediatrics’ Management and Board of Directors take its environmental, social and governance (“ESG”) responsibilities very seriously. We believe these areas are central to our business philosophy and ultimately generate increased shareholder value. Our internal ESG team is led by our COO & CFO and reports directly to our Governance and Nominating Committee.
OrthoPediatrics cares about our environmental impact while working in a highly regulated industry and we are certified according to ISO 13485.
A sub-committee focuses on reducing our environmental impact through energy-efficient resourcing and recycling.
OrthoPediatrics products are manufactured by a network of highly regulated suppliers who must meet rigorous qualifications. Product quality and patient safety are our highest priorities.
Suppliers are carefully selected and monitored, to ensure compliance with all applicable regulations and quality standards.
We undergo an annual review to ensure there are no Conflict Minerals used in the production of our products.
At OrthoPediatrics, we are a guided by a cause: to help children whose lives have been impacted by orthopedic conditions. This singular focus unites our employees worldwide and drives our business forward.
Since its founding, we estimate the Company has impacted the lives of over 230,000 children as well as their parents and loved ones.
We are committed to advancing the entire field of pediatric orthopedics, including training and educating the next generation of healthcare professionals.
We believe that a strong culture is key to our success, and we focus on continuous improvements in an engaging and positive work environment.
OrthoPediatrics associates complete an annual assessment survey, sponsored by the Indiana Chamber of Commerce, and we are proud of our record as a five-time winner of the “Best Places to Work in Indiana” award.
The Company and our associates regularly participate in philanthropic causes important to our local communities. We also partner with charitable organizations that provide pediatric orthopedic care around the world. In 2020 we were named as “Corporate Partner of the Year” by the World Pediatric Project – with whom we work to provide access to medical care for children in developing countries.
The Company has implemented a Global Ethics & Compliance Program that requires annual training. The Program includes the Company’s Code of Ethics & Business Conduct (“Code of Conduct”) Policy and Anti-Corruption Policy, and a series of other policies, procedures and trainings to provide relevant information for internal associates, our global sales network and Board of Directors.
The Code of Conduct policy describes the basis for how employees and partners should act dealing with customers, hospitals, surgeons, partners and fellow associates.
The Compliance Hotline and email enable employees and external partners to report any issues, including violations of the Company’s policies and procedures, violations of U.S. or international laws, and concerns about the Company’s accounting, internal controls or auditing related matters, suspected bribery, corruption, or violations of the Code of Conduct. The hotline and email are administered by an external third party and communicated directly to the Chairman of the Audit Committee of the Board.
The Board of Directors understands the value of diversity and will increase the diversity of the Board over the next 18 months. The Governance and Nominating Committee has engaged a global recruiting firm to assist in adding two diverse Board candidates.
The Company does not directly utilize paid lobbyists nor does it permit political donations to obtain or retain business or to gain an improper business advantage for the Company.
Cybersecurity continues to be a top priority; we have increased internal awareness and training while leveraging third-party providers to assist in safeguarding the Company.
The Company has a separate Executive Chairman of the Board and CEO.